AZ settles with generic challenger to Nexium
April 17, 2008Sales and Marketing
AstraZeneca has settled its legal battle with Indian generics company Ranbaxy Laboratories over the US patents on Nexium, AstraZeneca's biggest …
Shire plans tax move to Ireland
April 17, 2008Sales and Marketing
One of the UK's leading pharmaceutical companies is to shift its tax base to the Republic of Ireland to benefit …
Roche to buy Piramed
April 15, 2008Sales and Marketing MA, Piramed
Roche is set to pay $160 million (£315 million) to buy UK biotech company Piramed, a move which will further …
Olympian projects require world-class planning
April 14, 2008Research and Development clinical trials, project planning
The latest edition of the CMR International R&D Factbook shows that the mean time from protocol approval to final report …
Boehringer Ingelheim outpaces market
April 14, 2008Sales and Marketing resp
Strong growth in respiratory product Spiriva once again led the way for Boehringer Ingelheim, which has just published results for …
NHS poll shows shortfall in care and hand washing
April 14, 2008Less than half of NHS staff believes patient care is a top priority for trusts, according to a survey from …
Takeda buys up biotech Millennium
April 14, 2008Sales and Marketing
Takeda has acquired US biotech company Millennium in an effort to boost its global presence in oncology. The Japanese firm …
Merck obesity drug to continue at low dose
April 11, 2008Research and Development, Sales and Marketing
New data suggests Merck's taranabant drug can help obese patients lose weight, but safety concerns look to be behind higher …
Study confers protective benefits on Micardis
April 4, 2008Sales and Marketing cv
Boehringer Ingelheim's hypertension treatment Micardis has come out on top of Aventis's gold standard ACE inhibitor Tritace in a new …
UK clinical research is being transformed
April 4, 2008Research and Development UK, clinical trials
Politicians have been talking, reports have been published, a series of initiatives have been launched and a fist full of …
Trial fails to enhance Inegy’s prospects
April 4, 2008Sales and Marketing cv
Schering-Plough and Merck's much-touted anti-cholesterol combination Inegy has suffered a setback following a poor showing in the ENHANCE trial. Inegy …
Role of pharmacists to be extended
April 4, 2008Pharmacists are to be given a greater role in patient treatment and promoting good health under new government plans. The …
Make Alzheimer’s a top research priority, says public
April 1, 2008The British public wants a greater focus on research into Alzheimer's disease, according to an opinion poll conducted by the …
UCB’s Cimzia fails to appeal to European regulators
April 1, 2008Sales and Marketing EU
UCB's Crohn's disease drug Cimzia has been denied European approval for a second time after regulators said lacked sufficient evidence …
Latest news from Datamonitor
March 31, 2008Sales and Marketing
The impact of the US presidential race on healthcare IT The three leaders in the race for the US presidency; …
The role of audit in marketing excellence
March 28, 2008Sales and Marketing audit, excellence, marketing
The goal for any business leader, whether they run a company, business unit or brand, should always be 100% alignment …
Gardasil licence extension gets priority FDA review
March 28, 2008Sales and Marketing
Merck has received priority review status from the FDA for its application to extend the licence of its cervical cancer …
Accomplia gains limited NICE approval
March 28, 2008Sales and Marketing
Sanofi-Aventis' weight-loss pill Acomplia has been approved for prescription on the NHS, but only for patients who fail to respond …
Merck’s hepatitis B vaccine trial on hold
March 28, 2008Sales and Marketing
US regulators have placed a 'clinical hold' on one of the trials for Merck's hepatitis B vaccine Heplisav, raising questions …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
